Financial conflicts of interest in physicians' relationships with the pharmaceutical industry—self-regulation in the shadow of federal prosecution

DM Studdert, MM Mello… - New England Journal of …, 2004 - Mass Medical Soc
Studdert et al. describe recent efforts by the federal government and professional
organizations to tighten the regulation of financial associations between physicians and the …

Doctors and drug companies—scrutinizing influential relationships

EG Campbell - New England Journal of Medicine, 2007 - Mass Medical Soc
On September 6, Senators Charles Grassley and Herb Kohl introduced the Physician
Payments Sunshine Act. Eric Campbell discusses the implications of the bill, which would …

Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies

JE Perry, D Cox, AD Cox - Journal of Law, Medicine & Ethics, 2014 - cambridge.org
Financial relationships and business transactions between physicians and the health care
industry are common. These relationships take a variety of forms, including payments to …

Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?

D Grande - Journal of general internal medicine, 2010 - Springer
Concerns over the influence of pharmaceutical gifts on physicians have surged in recent
years. This has prompted wide ranging legislative proposals in numerous states and in the …

Payments to physicians: does the amount of money make a difference?

B Lo, D Grady - Jama, 2017 - jamanetwork.com
ThefederalOpenPaymentsdatabasemakesp… amount and type of payments from drug and
device companies to individual physicians. 1 It seems plausible that very large payments …

A ray of sunshine: transparency in physician-industry relationships is not enough

J Lexchin, A Fugh-Berman - Journal of General Internal Medicine, 2021 - Springer
Gifts from pharmaceutical and medical device companies to physicians in the United States
have been reported since 2014, through the Physician Payments Sunshine Act. Although …

New developments in managing physician-industry relationships

DJ Rothman, S Chimonas - JAMA, 2008 - jamanetwork.com
OVER THE PAST2YEARS, POLICIES GOVERNING THE RE-lationship between physicians
and pharmaceuti-calanddevicecompanieshaveundergonere… changes. A 2004 task force …

Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach

DL Coleman, AE Kazdin, LA Miller, JS Morrow… - Academic …, 2006 - journals.lww.com
A productive and ethical relationship between the pharmaceutical industry and physicians is
critical to improving drug discovery and public health. In response to concerns about …

Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?

TR Insel - JAMA, 2010 - jamanetwork.com
PSYCHIATRISTS HAVE RARELY ENJOYED A SURPLUS OF PUB-lic trust. During the past
3 years, public trust in psy-chiatry has been further undermined with accusations that several …

Health industry practices that create conflicts of interest: a policy proposal for academic medical centers

TA Brennan, DJ Rothman, L Blank, D Blumenthal… - Jama, 2006 - jamanetwork.com
Conflicts of interest between physicians' commitment to patient care and the desire of
pharmaceutical companies and their representatives to sell their products pose challenges …